DBV Technologies (DBVT) Operating Expenses (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Operating Expenses of $51.3 million for Q2 2026, up 20.42% year-on-year from $42.6 million in Q2 2025, and up 5.12% on a QoQ basis from $48.8 million in Q1 2026.
DBV Technologies (DBVT) Operating Expenses (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Operating Expenses for 7 consecutive years, with $51.3 million the latest figure, recorded in Q2 2026.
- Quarterly Operating Expenses rose 20.42% year-over-year to $51.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $182.8 million (up 45.38% YoY) and the FY2025 annual result came in at $152.7 million, up 26.46% from the prior year.
- Operating Expenses improved to $51.3 million in Q2 2026 per DBVT's latest filing, from $48.8 million in the prior quarter.
- Over the last five years, Operating Expenses for DBVT reached as high as $51.3 million in Q2 2026 and fell as low as $19.3 million in Q1 2022.
- A 5-year average of $31.5 million and a median of $28.7 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 123.71% — and 2023, when it sank 43.36%.
- Year by year, Operating Expenses stood at $36.7 million in 2022, then plunged by 43.36% to $20.8 million in 2023, then gained by 17.2% to $24.4 million in 2024, then jumped by 87.49% to $45.7 million in 2025, then grew by 12.27% to $51.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $51.3 million, $48.8 million, and $45.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 51.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.30 Mn |
| Mar 31, 2026 | 48.80 Mn |
| Dec 31, 2025 | 45.70 Mn |
| Sep 30, 2025 | 37.05 Mn |
| Jun 30, 2025 | 42.60 Mn |
| Mar 31, 2025 | 27.40 Mn |
| Dec 31, 2024 | 24.37 Mn |
| Sep 30, 2024 | 31.40 Mn |
| Jun 30, 2024 | 35.00 Mn |
| Mar 31, 2024 | 29.96 Mn |
| Dec 31, 2023 | 20.80 Mn |
| Sep 30, 2023 | 20.64 Mn |
| Jun 30, 2023 | 27.36 Mn |
| Mar 31, 2023 | 23.36 Mn |
| Dec 31, 2022 | 36.71 Mn |
| Sep 30, 2022 | 20.09 Mn |
| Jun 30, 2022 | 25.35 Mn |
| Mar 31, 2022 | 19.32 Mn |
| Dec 31, 2021 | 16.41 Mn |
| Sep 30, 2021 | 25.69 Mn |